Get the Stockscreener App
3.57
1.11%
-0.04
Endra Life Sciences Inc stock is traded at $3.57, with a volume of 4,908.
It is down -1.11% in the last 24 hours and down -20.84% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$3.61
Open:
$3.64
24h Volume:
4,908
Relative Volume:
0.11
Market Cap:
$4.16M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-0.00516
EPS:
-691.4213
Net Cash Flow:
$-8.08M
1W Performance:
-5.80%
1M Performance:
-20.84%
6M Performance:
-14.59%
1Y Performance:
-25.93%
1-Day Range:
$3.57
$3.78
1-Week Range:
$3.475
$4.03
52-Week Range:
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
3.57 | 4.21M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
509.82 | 198.06B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
214.94 | 155.50B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
617.20 | 51.80B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.88 | 36.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.83 | 32.29B | 3.17B | 642.63M | 539.81M | 10.77 |
Endra Life Sciences Inc Stock (NDRA) Latest News
Can ENDRA Life Sciences Inc. stock sustain free cash flow growth2025 Historical Comparison & Daily Profit Maximizing Trade Tips - mfd.ru
Resistance Check: What is the target price for ENDRA Life Sciences Inc stock2025 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Technical Analysis: Is ENDRA Life Sciences Inc being accumulated by smart moneyWeekly Stock Summary & Verified Short-Term Trading Plans - baoquankhu1.vn
Street Watch: Whats the MACD signal for ENDRA Life Sciences IncWeekly Investment Summary & Long-Term Safe Investment Ideas - baoquankhu1.vn
ENDRA Life Sciences (NASDAQ: NDRA) Gaining Attention as HYPE Token Surges See Why Now! FEED, SER, TRX, XHLD, BATL Inside - Barchart.com
FinancialContentENDRA Life Sciences (NASDAQ: NDRA) Gaining Attention as HYPE Token Surges See Why Now! FEED, SER, TRX, XHLD, BATL Inside - FinancialContent
ENDRA Life Sciences (NASDAQ: NDRA) Gaining Attention as HYPE - openPR.com
Smart Money: What is the PEG ratio of ENDRA Life Sciences Inc2025 Major Catalysts & Long-Term Growth Plans - baoquankhu1.vn
$5 Stocks: NDRA, IBRX, MOVE, RVLY Drawing Attention Watch Now! - openPR.com
MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, BNAI, NDRAJanuary 2026 Focus - openPR.com
MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, BNAI, NDRA – January 2026 Focus - Barchart.com
Why ENDRA Life Sciences Inc. stock attracts high net worth investorsPortfolio Update Summary & Real-Time Volume Triggers - ulpravda.ru
Will ENDRA Life Sciences Inc. stock benefit from automationChart Signals & Weekly Momentum Picks - Улправда
Can ENDRA Life Sciences Inc. stock attract ESG capital inflows2025 Short Interest & Real-Time Market Sentiment Alerts - Улправда
$5 Stocks Gaining Attention for 2026: EKSO, NDRA, ONTF, FLYE, RDZN See Why Inside - openPR.com
ENDRA Life Sciences Inc.Common Stock (Nasdaq:NDRA) Stock Quote - FinancialContent
Why ENDRA Life Sciences Inc. stock is favored by pension fundsMarket Risk Analysis & High Accuracy Trade Alerts - Улправда
What technical charts say about ENDRA Life Sciences Inc. stock2025 Investor Takeaways & Community Shared Stock Ideas - Улправда
Quarterly Risk: What technical charts say about ENDRA Life Sciences Inc. stockOptions Play & Long-Term Growth Portfolio Plans - Улправда
What hedge fund activity signals for ENDRA Life Sciences Inc. stockJuly 2025 Trends & Consistent Profit Trading Strategies - Улправда
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, GLSI IMNM) With a Next-Generation Treasury Strategy - Barchart.com
Endra Life Sciences shareholders approve share increase and board elections - Investing.com
Top Premarket Decliners - marketscreener.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
A Look at ENDRA Life Sciences Inc (NDRA) Shares in the Recent Past Indicates Growth - setenews.com
ENDRA Life Sciences (NASDAQ:NDRA) Price Target Lowered to $30.00 at Ascendiant Capital Markets - Defense World
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS Registered - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active - Barchart.com
Aug Rallies: How geopolitical tensions affect ENDRA Life Sciences Inc stockProfit Target & Weekly High Return Stock Forecasts - Bộ Nội Vụ
Ascendiant Capital Maintains ENDRA Life Sciences (NDRA) Buy Recommendation - Nasdaq
ENDRA Life Sciences (NDRA) Receives Adjusted Price Target with B - GuruFocus
Endra Life Sciences announces results from Taeus liver device feasibility study - MSN
ENDRA’s liver fat measurement device shows high accuracy at key thresholds - Investing.com Nigeria
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
ENDRA Life Sciences (NDRA) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
Endra Life Sciences (NDRA) Announces Promising Results from Live - GuruFocus
ENDRA Life Sciences stock falls after liver device study results By Investing.com - Investing.com Canada
Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use - Business Wire
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use - Yahoo Finance
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS® Liver Imaging Platform - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS Registered Liver Imaging Platform - openPR.com
ENDRA Life Sciences Inc. (NDRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Jobs Data: What technical charts say about ENDRA Life Sciences Inc. stock2025 Short Interest & Step-by-Step Swing Trade Plans - BỘ NỘI VỤ
ENDRA Life Sciences Announces Management Changes - TradingView — Track All Markets
ENDRA Life Sciences Inc. Announces Resignation of Michael Thornton as Chief Technology Officer, Effective November 28, 2025 - marketscreener.com
What analysts say about ENDRA Life Sciences Inc stockBlue Chip Stock Analysis & Free Trading Psychology Coaching - earlytimes.in
You might want to take a look at ENDRA Life Sciences Inc (NDRA) now - Setenews
NDRA registers 2.68M-share resale, pivots to HYPE crypto strategy - Stock Titan
Form DEF 14AOther definitive proxy statements - ADVFN
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):